Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Z. M. Bush, J. A. Longtine, T. Cunningham, D. Schiff, J. A. Jane, M. L. Vance, M. O. Thorner, E. R. Laws, M. B. S. LopesYear:
2010
Language:
english
DOI:
10.1210/jc.2010-0441
File:
PDF, 540 KB
english, 2010